Ep 155 [30 October 2024]: John Shon MD MS – RWD in a decentralized observational COVID biomarker study

Ep 155 [30 October 2024]: John Shon MD MS, Chief Technology Officer at SerImmune Inc. – We discussed leveraging highly multiplex serology assays to study SARS-CoV-2 antibody dynamics in individuals in response to vaccines and infections informing the study insights with RWD.

Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club

Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.